Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06865937 · ClinicalTrials.gov registry record · NA
Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
A NA study of Schizoaffective Disorder and Schizophenia Disorder, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT06865937: Recruiting NA study of Schizoaffective Disorder and Schizophenia Disorder, sponsored by University of California, San Diego.
NCT06865937 is a NA study of Schizoaffective Disorder and Schizophenia Disorder that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 125 participants, below the 171-participant average among 103 other Schizoaffective Disorder trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06865937, a NA study of Schizoaffective Disorder and Schizophenia Disorder, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial will test a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets social engagement in consumers with serious mental illness.
Primary Outcome
Ecological Momentary Assessment (EMA) is a method of remote data collection that involves repeatedly sampling a participant's current behaviors, thoughts, mood, and experiences in real time, in their natural environments. The primary outcome in this study will be the number of social interactions.
Conditions Studied
Interventions
- BEHAVIORAL Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE)
- BEHAVIORAL Supportive Contact (SC)
Study Locations (1)
California
- University of California - San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2028-09-30 |
| Phase | NA |
What NCT06865937 shows while recruiting
NCT06865937 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 171-participant average among 103 other Schizoaffective Disorder trials with a reported enrollment target (27% lower).
The record links to 2 conditions, with Schizoaffective Disorder appearing as the primary indexed condition, and to 2 interventions - of which Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) is the first listed.
NCT06865937 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06865937 about?
NCT06865937 is a clinical study titled "Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)". This randomized clinical trial will test a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets social engagement in consumers with serious mental illness.
What is the current status of trial NCT06865937?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-07-01. Estimated completion is 2028-09-30.
What conditions does trial NCT06865937 study?
This clinical trial studies the following conditions: Schizoaffective Disorder, Schizophenia Disorder.
What interventions are being tested in trial NCT06865937?
The interventions under investigation include: Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) (BEHAVIORAL), Supportive Contact (SC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06865937?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06865937 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizoaffective Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06865937's enrollment target sits among peer trials
125 26th of 103 higher than 78 of 103 other Schizoaffective Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizoaffective Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
RECRUITING · NA
-
Effectiveness of Motivation Skills Training (MST)
RECRUITING · NA
-
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
RECRUITING · NA
-
Prebiotic Treatment in People With Schizophrenia
RECRUITING · NA
-
Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI